Rivoceranib in Patients With Metastatic Thymic Epithelial Tumor
Clinical trial NCT06200233 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06200233
- Sponsor
- Samsung Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.